Bangying Su

Corporate Officer/Principal at Washington University in St. Louis

Consumer Services

Health Technology

Bangying Su active positions

Companies	Position	Start	End
Washington University in St. Louis	Corporate Officer/Principal	2010-01-24	-
The University of Alabama	Corporate Officer/Principal	2010-01-24	-

Companies	Position	Start	End
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Corporate Officer/Principal	2010-01-24	-

Peking University

Undergraduate Degree

International

United States	4
China	2

Operational

Corporate Officer/Principal	3
Undergraduate Degree	1

Sectoral

Consumer Services	4
Health Technology	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	1
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Health Technology

Private companies

Health Technology